MAZE
MAZE
NASDAQ · Pharmaceuticals

Maze Therapeutics Inc

Small-Cap Stocks Pharmaceutical Stocks Healthcare Stocks
$22.52
-0.92 (-3.92%)
As of Sep 20, 10:05 PM ET ·
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Buy 17 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target +317.0% upside
Low Target $74.59
Average Target $93.90
High Target $145.81
Current Price $22.52
Current
$22.52
Target
$93.90
$74.59 $93.90 avg $145.81
Scenario Analysis
Bear Case
$74.59
231.2%
Low target
Base Case
$93.90
+317.0%
Avg target
Bull Case
$145.81
+547.5%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$53.65
-58.0% from high
52-Week Low
$22.45
+0.3% from low
50-Day SMA
$42.71
-47.3% vs SMA
200-Day SMA
$25.83
-12.8% vs SMA
RSI (14)
50.1
Neutral
Target vs 52W High
$93.90
+75.0% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
 Strong Buy 38 79% $1,330.33 +13.7%
RDY
Dr. Reddy's Laboratories
 Strong Sell 45 31% — +0.0%
JNJ
Johnson & Johnson
 Buy 31 71% $299.55 +11.3%
MRK
Merck & Co. Inc.
 Buy 36 72% $159.27 +5.5%
PFE
Pfizer Inc.
 Hold 36 39% $33.90 +21.4%
BMY
Bristol-Myers Squibb Co
 Hold 35 43% $174.50 +180.3%
RPRX
Royalty Pharma Plc- Cl A
 Strong Buy 16 88% $36.26 -38.0%
ZTS
Zoetis Inc
 Hold 24 50% $209.87 +188.0%